PAICON participated in DMEA 2025 in Berlin, one of Europe’s leading digital health events, showcasing our commitment to transforming real-world, genetically and technologically diverse cancer data into robust AI models for diagnostics, drug development, and clinical research.

Over the course of three inspiring days, the PAICON team was represented by our CEO and co-founder Dr. Manasi A-Ratnaparkhe, who delivered our Nova Award pitch, alongside COO Danny Quick, Quality Manager Yuliya Kucherenko, and Senior Data Manager Myroslav Zapukhlyak. Together, they welcomed visitors from the pharmaceutical, healthcare, tech, and research sectors from around the globe. Conversations sparked exciting ideas about how AI can truly serve everyone, not just a privileged few. A heartfelt thank you to all the visitors who stopped by to explore collaboration opportunities. Your openness and shared drive to build better data and AI solutions inspire us to push even further.

DMEA Nova Award: A Moment of Recognition

A defining highlight of DMEA was winning the prestigious DMEA Nova Award, one of Europe’s top recognitions in digital healthcare innovation.

Our CEO and co-founder, Dr. Manasi A-Ratnaparkhe, delivered an standout pitch that captured both the jury’s and the audience’s hearts. Her message was clear and urgent: 84% of the world’s population remains invisible to cancer AI today. At PAICON, we believe data diversity is not optional, but it’s essential for creating AI that genuinely works for all.

“Manasi doesn’t just pitch — she inspires. Her vision becomes the audience’s vision. Amid the current AI craze, she challenged the status quo and offered a fresh perspective on what AI can and should be.”

Winning the Nova Award was especially meaningful, not only because a distinguished jury recognized our vision, but because the public voted for us too. This public vote sends a powerful signal: people are ready to demand inclusive, equitable healthcare innovation.

At a record-breaking DMEA with 20,500 visitors, 900 exhibitors from nearly 30 countries, and 470 speakers across 200 sessions, standing out was no small feat. We are incredibly honored to have our mission recognized on this influential stage.

Moments That Mattered

• DMEA Nova Award Pitch: Delivered by Dr. Manasi A-Ratnaparkhe, bringing energy, urgency, and inspiration to the DMEA stage.
• DMEA Nova Award Win: Celebrating recognition for PAICON’s unique approach to AI-driven healthcare innovation.
• Metropol Party: A night of lights, music, and unforgettable memories — a perfect way to celebrate the spirit of connection and innovation.
• Engaging and Networking: Building relationships with healthcare, tech, and pharma leaders to drive future collaborations.

Looking Ahead: The #Remaining84

Now, the real work begins. While winning the DMEA Nova Award was a proud moment, it is also a call to action. As we move forward, we are more determined than ever to fulfill our mission: Making the Remaining84 count.

We would like to express our sincere gratitude to the DMEA jury and audience for supporting our vision, to our partners for their continued trust, and above all, to the entire PAICON team, whose passion and hard work made this success possible.

Together, we are working toward a future where AI includes everyone and leaves no one behind.